 |
||||
|
||||
|
||||
|
||||
Previous Article | Next Article
Volume 17, Number 21, Issue of November 1, 1997 pp. 8147-8155
Copyright ©1997 Society for NeuroscienceBidirectional Regulation of DARPP-32 Phosphorylation by Dopamine
Received May 27, 1997; revised July 18, 1997; accepted Aug. 13, 1997.
Akinori Nishi, Gretchen L. Snyder, and Paul Greengard Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, New York 10021
Dopamine has been shown to stimulate phosphorylation of DARPP-32, a phosphoprotein highly enriched in medium-sized spiny neurons of the neostriatum. Here, we investigated the contribution of D1-like and D2-like dopamine receptors in the regulation of DARPP-32 phosphorylation in mouse striatal slices. D1-like and D2-like receptors had opposing effects on the state of DARPP-32 phosphorylation. The D1 receptor agonist SKF82526 increased DARPP-32 phosphorylation. In contrast, the D2 receptor agonist quinpirole decreased basal as well as D1 agonist-, forskolin-, and 8-bromo-cAMP-stimulated phosphorylation of DARPP-32. The ability of quinpirole to decrease D1-stimulated DARPP-32 phosphorylation was calcium-dependent and was blocked by the calcineurin inhibitor cyclosporin A, suggesting that the D2 effect involved an increase in intracellular calcium and activation of calcineurin. In support of this interpretation, Ca2+-free/EGTA medium induced a greater than 60-fold increase in DARPP-32 phosphorylation and abolished the ability of quinpirole to dephosphorylate DARPP-32. The antipsychotic drug raclopride, a selective D2 receptor antagonist, increased phosphorylation of DARPP-32 under basal conditions and in D2 agonist-treated slices. The results of this study demonstrate that dopamine exerts a bidirectional control on the state of phosphorylation of DARPP-32.
Key words: DARPP-32; dopamine; D2 receptor; phosphorylation; neostriatum; calcineurin; raclopride
This article has been cited by other articles:
F. J. Bode, M. Stephan, H. Suhling, R. Pabst, R. H. Straub, K. A. Raber, M. Bonin, H. P. Nguyen, O. Riess, A. Bauer, et al.
Sex differences in a transgenic rat model of Huntington's disease: decreased 17{beta}-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males
Hum. Mol. Genet., September 1, 2008; 17(17): 2595 - 2609.
[Abstract] [Full Text] [PDF]
S. Kitaoka, T. Furuyashiki, A. Nishi, T. Shuto, S. Koyasu, T. Matsuoka, M. Miyasaka, P. Greengard, and S. Narumiya
Prostaglandin E2 Acts on EP1 Receptor and Amplifies Both Dopamine D1 and D2 Receptor Signaling in the Striatum
J. Neurosci., November 21, 2007; 27(47): 12900 - 12907.
[Abstract] [Full Text] [PDF]
E. Santini, E. Valjent, A. Usiello, M. Carta, A. Borgkvist, J.-A. Girault, D. Herve, P. Greengard, and G. Fisone
Critical Involvement of cAMP/DARPP-32 and Extracellular Signal-Regulated Protein Kinase Signaling in L-DOPA-Induced Dyskinesia
J. Neurosci., June 27, 2007; 27(26): 6995 - 7005.
[Abstract] [Full Text] [PDF]
J. A. Rosenkranz and D. Johnston
State-Dependent Modulation of Amygdala Inputs by Dopamine-Induced Enhancement of Sodium Currents in Layer V Entorhinal Cortex
J. Neurosci., June 27, 2007; 27(26): 7054 - 7069.
[Abstract] [Full Text] [PDF]
J.-H. Ahn, J. Y. Sung, T. McAvoy, A. Nishi, V. Janssens, J. Goris, P. Greengard, and A. C. Nairn
The B''/PR72 subunit mediates Ca2+-dependent dephosphorylation of DARPP-32 by protein phosphatase 2A
PNAS, June 5, 2007; 104(23): 9876 - 9881.
[Abstract] [Full Text] [PDF]
M. F. Perez, F. J. White, and X.-T. Hu
Dopamine D2 Receptor Modulation of K+ Channel Activity Regulates Excitability of Nucleus Accumbens Neurons at Different Membrane Potentials
J Neurophysiol, November 1, 2006; 96(5): 2217 - 2228.
[Abstract] [Full Text] [PDF]
M. Hamada, J. P. Hendrick, G. R. Ryan, M. Kuroiwa, H. Higashi, M. Tanaka, A. C. Nairn, P. Greengard, and A. Nishi
Nicotine Regulates DARPP-32 (Dopamine- and cAMP-Regulated Phosphoprotein of 32 kDa) Phosphorylation at Multiple Sites in Neostriatal Neurons
J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 872 - 878.
[Abstract] [Full Text] [PDF]
X.-T. Hu, Y. Dong, X.-F. Zhang, and F. J. White
Dopamine D2 Receptor-Activated Ca2+ Signaling Modulates Voltage-Sensitive Sodium Currents in Rat Nucleus Accumbens Neurons
J Neurophysiol, March 1, 2005; 93(3): 1406 - 1417.
[Abstract] [Full Text] [PDF]
F. Worgotter and B. Porr
Temporal Sequence Learning, Prediction, and Control: A Review of Different Models and Their Relation to Biological Mechanisms
Neural Comput., February 1, 2005; 17(2): 245 - 319.
[Abstract] [Full Text] [PDF]
A. Nishi, Y. Watanabe, H. Higashi, M. Tanaka, A. C. Nairn, and P. Greengard
Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades
PNAS, January 25, 2005; 102(4): 1199 - 1204.
[Abstract] [Full Text] [PDF]
M. J. Frank
Dynamic Dopamine Modulation in the Basal Ganglia: A Neurocomputational Account of Cognitive Deficits in Medicated and Nonmedicated Parkinsonism
J. Cogn. Neurosci., January 1, 2005; 17(1): 51 - 72.
[Abstract] [Full Text] [PDF]
M. J. Frank, L. C. Seeberger, and R. C. O'Reilly
By Carrot or by Stick: Cognitive Reinforcement Learning in Parkinsonism
Science, December 10, 2004; 306(5703): 1940 - 1943.
[Abstract] [Full Text] [PDF]
H. Trantham-Davidson, L. C. Neely, A. Lavin, and J. K. Seamans
Mechanisms Underlying Differential D1 versus D2 Dopamine Receptor Regulation of Inhibition in Prefrontal Cortex
J. Neurosci., November 24, 2004; 24(47): 10652 - 10659.
[Abstract] [Full Text] [PDF]
S. V. Rakhilin, P. A. Olson, A. Nishi, N. N. Starkova, A. A. Fienberg, A. C. Nairn, D. J. Surmeier, and P. Greengard
A Network of Control Mediated by Regulator of Calcium/Calmodulin-Dependent Signaling
Science, October 22, 2004; 306(5696): 698 - 701.
[Abstract] [Full Text] [PDF]
J.-M. Beaulieu, T. D. Sotnikova, W.-D. Yao, L. Kockeritz, J. R. Woodgett, R. R. Gainetdinov, and M. G. Caron
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade
PNAS, April 6, 2004; 101(14): 5099 - 5104.
[Abstract] [Full Text] [PDF]
K. E. Culm and R. P. Hammer Jr.
Recovery of Sensorimotor Gating without G Protein Adaptation after Repeated D2-Like Dopamine Receptor Agonist Treatment in Rats
J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 487 - 494.
[Abstract] [Full Text] [PDF]
H. CEULEMANS and M. BOLLEN
Functional Diversity of Protein Phosphatase-1, a Cellular Economizer and Reset Button
Physiol Rev, January 1, 2004; 84(1): 1 - 39.
[Abstract] [Full Text] [PDF]
S.-P. Onn, A. A. Fienberg, and A. A. Grace
Dopamine Modulation of Membrane Excitability in Striatal Spiny Neurons is Altered in DARPP-32 Knockout Mice
J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 870 - 879.
[Abstract] [Full Text] [PDF]
N. Lindgren, A. Usiello, M. Goiny, J. Haycock, E. Erbs, P. Greengard, T. Hokfelt, E. Borrelli, and G. Fisone
Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites
PNAS, April 1, 2003; 100(7): 4305 - 4309.
[Abstract] [Full Text] [PDF]
Y. S. Eyny and J. C. Horvitz
Opposing Roles of D1 and D2 Receptors in Appetitive Conditioning
J. Neurosci., March 1, 2003; 23(5): 1584 - 1587.
[Abstract] [Full Text] [PDF]
A. Nishi, F. Liu, S. Matsuyama, M. Hamada, H. Higashi, A. C. Nairn, and P. Greengard
Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling
PNAS, February 4, 2003; 100(3): 1322 - 1327.
[Abstract] [Full Text] [PDF]
T.-S. Tang, H. Tu, Z. Wang, and I. Bezprozvanny
Modulation of Type 1 Inositol (1,4,5)-Trisphosphate Receptor Function by Protein Kinase A and Protein Phosphatase 1alpha
J. Neurosci., January 15, 2003; 23(2): 403 - 415.
[Abstract] [Full Text] [PDF]
F. Liu, D. M. Virshup, A. C. Nairn, and P. Greengard
Mechanism of Regulation of Casein Kinase I Activity by Group I Metabotropic Glutamate Receptors
J. Biol. Chem., November 15, 2002; 277(47): 45393 - 45399.
[Abstract] [Full Text] [PDF]
K. A. Albert, H. C. Hemmings Jr, A. I. B. Adamo, S. G. Potkin, S. Akbarian, C. A. Sandman, C. W. Cotman, W. E. Bunney Jr, and P. Greengard
Evidence for Decreased DARPP-32 in the Prefrontal Cortex of Patients With Schizophrenia
Arch Gen Psychiatry, August 1, 2002; 59(8): 705 - 712.
[Abstract] [Full Text] [PDF]
P. Svenningsson, E. T. Tzavara, J. M. Witkin, A. A. Fienberg, G. G. Nomikos, and P. Greengard
Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac)
PNAS, March 5, 2002; 99(5): 3182 - 3187.
[Abstract] [Full Text] [PDF]
P. Svenningsson, E. T. Tzavara, F. Liu, A. A. Fienberg, G. G. Nomikos, and P. Greengard
DARPP-32 mediates serotonergic neurotransmission in the forebrain
PNAS, March 5, 2002; 99(5): 3188 - 3193.
[Abstract] [Full Text] [PDF]
X. Zhen, C. Torres, H.-Y. Wang, and E. Friedman
Prenatal Exposure to Cocaine Disrupts D1A Dopamine Receptor Function Via Selective Inhibition of Protein Phosphatase 1 Pathway in Rabbit Frontal Cortex
J. Neurosci., December 1, 2001; 21(23): 9160 - 9167.
[Abstract] [Full Text] [PDF]
P. Greengard
The Neurobiology of Slow Synaptic Transmission
Science, November 2, 2001; 294(5544): 1024 - 1030.
[Abstract] [Full Text] [PDF]
F. Liu, X.-H. Ma, J. Ule, J. A. Bibb, A. Nishi, A. J. DeMaggio, Z. Yan, A. C. Nairn, and P. Greengard
Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors
PNAS, September 25, 2001; 98(20): 11062 - 11068.
[Abstract] [Full Text] [PDF]
P. Calabresi, P. Gubellini, B. Picconi, D. Centonze, A. Pisani, P. Bonsi, P. Greengard, R. A. Hipskind, E. Borrelli, and G. Bernardi
Inhibition of Mitochondrial Complex II Induces a Long-Term Potentiation of NMDA-Mediated Synaptic Excitation in the Striatum Requiring Endogenous Dopamine
J. Neurosci., July 15, 2001; 21(14): 5110 - 5120.
[Abstract] [Full Text] [PDF]
J. K. Seamans, N. Gorelova, D. Durstewitz, and C. R. Yang
Bidirectional Dopamine Modulation of GABAergic Inhibition in Prefrontal Cortical Pyramidal Neurons
J. Neurosci., May 15, 2001; 21(10): 3628 - 3638.
[Abstract] [Full Text] [PDF]
S. Hernandez-Lopez, T. Tkatch, E. Perez-Garci, E. Galarraga, J. Bargas, H. Hamm, and D. J. Surmeier
D2 Dopamine Receptors in Striatal Medium Spiny Neurons Reduce L-Type Ca2+ Currents and Excitability via a Novel PLC{beta}1-IP3-Calcineurin-Signaling Cascade
J. Neurosci., December 15, 2000; 20(24): 8987 - 8995.
[Abstract] [Full Text] [PDF]
A. Nishi, J. A. Bibb, G. L. Snyder, H. Higashi, A. C. Nairn, and P. Greengard
Amplification of dopaminergic signaling by a positive feedback loop
PNAS, October 23, 2000; (2000) 220410397.
[Abstract] [Full Text]
P. Svenningsson, M. Lindskog, C. Ledent, M. Parmentier, P. Greengard, B. B. Fredholm, and G. Fisone
Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors
PNAS, February 15, 2000; 97(4): 1856 - 1860.
[Abstract] [Full Text] [PDF]
S. K. Mani, A. A. Fienberg, J. P. O'Callaghan, G. L. Snyder, P. B. Allen, P. K. Dash, A. N. Moore, A. J. Mitchell, J. Bibb, P. Greengard, et al.
Requirement for DARPP-32 in Progesterone-Facilitated Sexual Receptivity in Female Rats and Mice
Science, February 11, 2000; 287(5455): 1053 - 1056.
[Abstract] [Full Text]
Z. Yan, J. Feng, A. A. Fienberg, and P. Greengard
D2 dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons
PNAS, September 28, 1999; 96(20): 11607 - 11612.
[Abstract] [Full Text] [PDF]
F. D. Smith, G. S. Oxford, and S. L. Milgram
Association of the D2 Dopamine Receptor Third Cytoplasmic Loop with Spinophilin, a Protein Phosphatase-1-interacting Protein
J. Biol. Chem., July 9, 1999; 274(28): 19894 - 19900.
[Abstract] [Full Text] [PDF]
G. L. Snyder, A. A. Fienberg, R. L. Huganir, and P. Greengard
A Dopamine/D1 Receptor/Protein Kinase A/Dopamine- and cAMP-Regulated Phosphoprotein (Mr 32 kDa)/Protein Phosphatase-1 Pathway Regulates Dephosphorylation of the NMDA Receptor
J. Neurosci., December 15, 1998; 18(24): 10297 - 10303.
[Abstract] [Full Text] [PDF]
A. A. Fienberg, N. Hiroi, P. G. Mermelstein, W. Song, G. L. Snyder, A. Nishi, A. Cheramy, J. P. O'Callaghan, D. B. Miller, D. G. Cole, et al.
DARPP-32: Regulator of the Efficacy of Dopaminergic Neurotransmission
Science, August 7, 1998; 281(5378): 838 - 842.
[Abstract] [Full Text]
T. Blank, I. Nijholt, U. Teichert, H. Kugler, H. Behrsing, A. Fienberg, P. Greengard, and J. Spiess
The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-D-aspartate responses
PNAS, December 23, 1997; 94(26): 14859 - 14864.
[Abstract] [Full Text] [PDF]
S. Leclerc, M. Garnier, R. Hoessel, D. Marko, J. A. Bibb, G. L. Snyder, P. Greengard, J. Biernat, Y.-Z. Wu, E.-M. Mandelkow, et al.
Indirubins Inhibit Glycogen Synthase Kinase-3beta and CDK5/P25, Two Protein Kinases Involved in Abnormal Tau Phosphorylation in Alzheimer's Disease. A PROPERTY COMMON TO MOST CYCLIN-DEPENDENT KINASE INHIBITORS?
J. Biol. Chem., January 5, 2001; 276(1): 251 - 260.
[Abstract] [Full Text] [PDF]
E. Bofill-Cardona, O. Kudlacek, Q. Yang, H. Ahorn, M. Freissmuth, and C. Nanoff
Binding of Calmodulin to the D2-Dopamine Receptor Reduces Receptor Signaling by Arresting the G Protein Activation Switch
J. Biol. Chem., October 13, 2000; 275(42): 32672 - 32680.
[Abstract] [Full Text] [PDF]
J. A. Bibb, A. Nishi, J. P. O'Callaghan, J. Ule, M. Lan, G. L. Snyder, A. Horiuchi, T. Saito, S.-i. Hisanaga, A. J. Czernik, et al.
Phosphorylation of Protein Phosphatase Inhibitor-1 by Cdk5
J. Biol. Chem., April 20, 2001; 276(17): 14490 - 14497.
[Abstract] [Full Text] [PDF]
J. A. Bibb, Z. Yan, P. Svenningsson, G. L. Snyder, V. A. Pieribone, A. Horiuchi, A. C. Nairn, A. Messer, and P. Greengard
Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice
PNAS, June 6, 2000; 97(12): 6809 - 6814.
[Abstract] [Full Text] [PDF]
A. Nishi, J. A. Bibb, G. L. Snyder, H. Higashi, A. C. Nairn, and P. Greengard
Amplification of dopaminergic signaling by a positive feedback loop
PNAS, November 7, 2000; 97(23): 12840 - 12845.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|